Re-analyzing the data from the ITP

I was reading about how using EGCG present in tea extends the median lifespan of rats +13% by protecting their liver and kidneys.

When I remembered this contradicts what have been found in the ITP using Green Tea Extract. So diggning a little bit deeper I run into this study:

The Gehan test identifies life-extending compounds overlooked by the log-rank test in the NIA Interventions Testing Program: Metformin, Enalapril, caffeic acid phenethyl ester, green tea extract, and 17-dimethylaminoethylamino-17-demethoxygeldanamycin hydrochloride

It looks like there are plenty of compunds that can be an advantage early on and they may bring some disadvantage later in life. Too much green tea seems to be one of those.

5 Likes

From the paper:

“Three drugs that had been identified to extend lifespan using the log-rank test no longer had statistically significant effects according to the Gehan test: acarbose in females at 400 ppm and 1000 ppm (Fig. S2A and S2B), butanediol in females (Fig. S2C), and glycine in males (Fig. S2D)”

So much conflicting information all the time

(post deleted by author)

If I understand correctly, this only means that the life extension is happening mostly at the end of the data. So this test is not picking it up.